SRTA has undergone a complete business transformation from Blade Air Mobility (passenger aviation) to Strata Critical Medical (time-critical healthcare logistics), representing a fundamental pivot in business model and market focus.
This represents a dramatic strategic shift from a passenger aviation company developing electric vertical aircraft technology to a specialized medical logistics provider focused on organ transport and healthcare services. The company has completely repositioned itself in a different industry with different risk profiles, regulatory environments, and growth prospects, requiring investors to reassess the investment thesis entirely.
Despite the massive business transformation, financial performance shows mixed but generally positive trends with net income swinging dramatically positive from -$27.3M to +$41.3M, gross profit growing 39% to $41.1M, and cash position strengthening 68.5% to $31.0M. However, operating cash flow deteriorated significantly from -$2.5M to -$48.9M, suggesting potential working capital challenges or timing differences, while the 85% increase in accounts receivable and 34% rise in total liabilities indicate the company is managing higher volumes but with extended collection cycles. The overall picture suggests a growing business with improved profitability but concerning cash flow dynamics that warrant close monitoring.
Operating cash flow fell 1841.8% — earnings quality concerns; investigate working capital changes and non-cash items.
Net income grew 251.4% — bottom-line growth signals improving overall business health.
Receivables surged 85.1% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Capex reduced 68.9% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Cash position surged 68.5% — strong cash generation or capital raise providing significant financial cushion.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
Liabilities grew 33.6% — significant increase in debt or obligations, assess impact on financial flexibility.
Asset base grew 26.8% — expansion through organic growth, acquisitions, or capital deployment.
Equity base grew 25.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →